| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±2.8% | +0.4% | over-priced |
| 05/05/2026 | ±2.4% | +1.0% | over-priced |
| 02/27/2026 | ±2.6% | +1.6% | over-priced |
| 11/04/2025 | ±2.1% | -0.9% | over-priced |
| 08/05/2025 | ±2.6% | +0.7% | over-priced |
| 05/06/2025 | ±1.9% | +0.1% | over-priced |
| 02/28/2025 | ±1.8% | +0.9% | over-priced |
| 11/05/2024 | ±1.7% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.20 | $2.0B | $50M |
| Q1 FY2026 | $0.66 | $2.7B | $169M |
| Q4 FY2025 | — | $2.6B | $7M |
| Q3 FY2025 | $0.16 | $2.7B | $40M |
IFF (IFF) reports in 7 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 0.7% on average — the market has systematically over-priced IFF's earnings risk. Fundamentals into the print: EPS down 91.6% year-over-year, revenue down 29.3%. QuantLogix's live 5-factor engine currently reads IFF as a buy at 70/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →